Bacteriophage Inhibition by Serum *

نویسندگان

  • M. L. Rakieten
  • G. Zalkan
  • T. L. Rakieten
چکیده

The inactivation of staphylococcus bacteriophage by an artificially produced anti-phagic serum was first reported by Gratia and Jaumain", who also found that normal rabbit serum inhibits staphy phage,-in some instances to a titer. as high as 1: 500. More recently it has been observed (Rosenthal29, Raiga24 25, Biglieri and Fischer4, Applebaum and MacNeal2, Colvin8, and Evans"0) that normal human serum, as well as pus, possesses the power to inhibit staphylococcus and streptococcus bacteriophages. Red blood cells do not influence the action of either staphylococcus or coli bacteriophage. The early studies of d'Herelle'8 led him to state that normal serum has no effect on bacteriophage. At that time he was chiefly concerned with bacteriophages active against members of the enteric group-chiefly coli and dysentery. Since it is rare to find a human serum which inhibits coli bacteriophage, d'Herelle's statement concerning the effect of serum on these phages still holds true. However, anti-coli bacteriophagic serum may be artificially produced following the technic of Bordet and Ciuca5. The term anti-phage, descriptive of the phage-inhibiting principle in serum, was proposed by Sonnenschein". He observed that normal human serum contains no anti-phage for paratyphoid B bacteriophage, but that the serum of an individual infected with B. paratyphosus B and the serum of a carrier of this organism were inhibitory to the bacteriophage. He, therefore, proposed the use of specific bacteriophage and anti-phage for diagnostic serological reactions. Katsu'9 attempted to utilize this method for the diagnosis of Flexner dysentery, but his results were too inconsistent to be of value. Raiga2" has studied this test in connection with therapeutic failure in cases of staphylococcus infection treated with bacteriophage. In those individuals who failed to respond to phage given locally or intravenously, he found in their serum anti-staphylococcus phage antibody, and in addition a considerable amount of anti-streptococcus phagic principle. He deduces that it is the presence of the latter that nullifies the action of the bacteriophage. Both of these prin-

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effect of Isolated Specific Lytic Phage against Growth and Biofilm Inhibition of Streptococcus mutans and Streptococcus sanguinis Isolated from Decayed Dental Plaque

Background and purpose: Despite advances in oral health and dental industry, tooth decay remains one of the most common oral diseases. One of the new methods to combat dental plaque, which is the main cause of caries, is using specific lytic bacteriophage. This study aimed to investigate the effect of isolated specific lytic phage against growth and biofilm inhibition of Streptococcus mutans an...

متن کامل

Lytic Activity of Isolated Phage from Milk Against Extended-Spectrum Beta-Lactamase Escherichia coli

 Background and purpose: Escherichia coli (E.coli) is the most common cause of urinary tract infection. The treatment strategy has been hampered by the emergence of broad-spectrum beta-lactamase-producing E.coli and its resistance to most antibiotics. Bacteriophages are suggested as an alternative treatment option. This study aimed at evaluating the lytic activity of isolated phage from unpaste...

متن کامل

Prevention of bacteriophage adsorption to Staphylococcus aureus by immunoglobulin G.

Normal human and rabbit sera when incubated with Staphylococcus aureus inhibit the adsorption of bacteriophages. The bacteriophage adsorption was also inhibited by separated normal immunoglobulin M (IgM), F(ab')(2), and Fab-fragments of IgG. No inhibition was obtained with myeloma IgG or Fc-fragments of normal human and rabbit IgG. The results indicate that the serum inhibition of bacteriophage...

متن کامل

Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody

Objective(s): Filamentous bacteriophage M13 was genetically engineered to specifically target mammalian cells for gene delivery purpose. Materials and Methods: A vascular endothelial growth factor receptor 2 (VEGFR2)-specific nanobody was genetically fused to the capsid gene III of M13 bacteriophage (pHEN4/3VGR19). A mammalian expression construct containing Cop-green fluorescent protein (Cop-G...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Yale Journal of Biology and Medicine

دوره 7  شماره 

صفحات  -

تاریخ انتشار 2008